Literature DB >> 33477036

An induced pluripotent stem cell line (GZHMCi003-A) derived from a fetus with exon 3 heterozygous deletion in RUNX2 gene causing cleidocranial dysplasia.

Min Chen1, Sheng Mou Lin2, Nan Li3, Yingting Li3, Yufan Li3, Luting Zhang3.   

Abstract

Cleidocranial dysplasia (CCD; MIM #119600) is an autosomal dominant genetic disorder caused by heterozygous loss-of-function mutation of the RUNX2 gene, which is important in the differentiation of osteoblasts and maturation of chondrocytes. In this study, we generated an induced pluripotent stem cell line GZHMCi003-A derived from umbilical cord blood mononuclear cells (UCBMCs) of a fetus with heterozygous deletion of the exon 3 in RUNX2 gene. This iPSC line is an ideal in vitro model to study the pathological mechanism and the treatment of CCD.
Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Year:  2021        PMID: 33477036     DOI: 10.1016/j.scr.2021.102166

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  3 in total

Review 1.  The Induced Pluripotent Stem Cells in Articular Cartilage Regeneration and Disease Modelling: Are We Ready for Their Clinical Use?

Authors:  Michał S Lach; Monika A Rosochowicz; Magdalena Richter; Inga Jagiełło; Wiktoria M Suchorska; Tomasz Trzeciak
Journal:  Cells       Date:  2022-02-03       Impact factor: 6.600

2.  A Novel 90-kbp Deletion of RUNX2 Associated with Cleidocranial Dysplasia.

Authors:  Yanli Zhang; Xiaohong Duan
Journal:  Genes (Basel)       Date:  2022-06-23       Impact factor: 4.141

3.  Fetal Nasal Bone Hypoplasia in the Second Trimester as a Marker of Multiple Genetic Syndromes.

Authors:  Hanna Moczulska; Marcin Serafin; Katarzyna Wojda; Maciej Borowiec; Piotr Sieroszewski
Journal:  J Clin Med       Date:  2022-03-10       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.